Vivimed Labs Limited (VIVIMEDLAB) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE526G01021
Key metrics
- Market Cap
- ₹54 Cr
- P/E Ratio
- —
- EPS
- -21.13
- Book Value
- -25.39
- P/B Ratio
- —
- ROE
- 83.81%
- ROCE
- -95.57%
- Debt / Equity
- -1.89
- Net Margin
- -252.14%
- Revenue Growth
- -39.8%
- Profit Growth
- -452.15%
- Dividend Yield
- —
- 52W High
- ₹29.40
- 52W Low
- ₹4.75
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Vivimed Labs Limited
Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Promoter Holding
- 14.92%
The full Vivimed Labs Limited analysis
Create a free account to open the complete VIVIMEDLAB deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.